Hereditary angioedema in a family presenting as transient periarthritis

Journal of Clinical Rheumatology

Volumn 14, Issue 5, 2008, Pages 289-291

  Adhikesavan, Leena G ^a   Olenginski, Thomas P ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

C1 inhibitor protein; Complement; Hereditary angioedema; Periarthritis

Indexed keywords

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPLEMENT SYSTEM; FEMALE; GENETIC COUNSELING; HUMAN; LABORATORY TEST; PERIARTHRITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; GENETICS; IMMUNOLOGY; PHYSIOLOGY; TIME;

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4;

ANGIOEDEMA, HEREDITARY; COMPLEMENT C1; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C4; FEMALE; HUMANS; PERIARTHRITIS; TIME FACTORS; YOUNG ADULT;

EID: 58949083135     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181886ef9     Document Type: Article

References (33)

1. Circolo A, Strunk RC. Hereditary angioedema-understanding the basis of C1 inhibitor deficiency. The Immunologist. 1997;5:166-170.
2. Bowen T, Cicardi M, Farkas H, et al. Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol. 2004;114:629-637.
3. Bork K, Gul D, Dewald G. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol. 2006;154:542-545.
4. Binkley KE, Davis AE III. Estrogen-dependent inherited angioedema. Transfus Apheresis Sci. 2003;29:215-219.
5. Milton JL. On giant urticaria. Edinb Med J. 1876;22:513-26.
6. Quincke HI. Uber akutes umschriebenes Hautodem. Monatsh Prakt Dermatol. 1882;1:129-131.
7. Osler W. Hereditary angioneurotic edema. Am J Med Sci. 1888;95:362-367.
8. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1-esterase. Am J Med. 1963;35:37-44.
9. Pappalardo E, Cicardi M, Duponchel C, et al. Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 2000;106:1147-1154.
10. Nussberger J, Cugno M, Amstutz C, et al. Plasma bradykinin in angiooedema. Lancet. 1998;351:1693-1697.
11. Han ED, MacFarlane RC, Mulligan AN, et al. Increased vascular permeability in C1 inhibitor-deficient mice mediated by bradykinin type 2 receptor. J Clin Invest. 2002;109:1057-1063.
12. Caldwell JR, Ruddy S, Schur PH, et al. Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol. 1972;1:39-52.
13. Grace RJ, Jacob A, Mainwaring CJ, et al. Acquired C1 esterase inhibitor deficiency as manifestation of T-cell lymphoproliferative disorder. Lancet. 1990;336:118.
14. Cohen SH, Koethe SM, Korin F, et al. Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. J Allergy Clin Immunol. 1978;62:217-221.
15. Qaseem T, Paterson WD, Jardine GWH, et al. Acquired C1-inhibitor deficiency preceding malignant lymphoma by 7 years. J R Soc Med. 1991;84:628.
16. Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med. 1987;316:1360-1366.
17. Zuraw BL, Altman LC. Acute consumption of C1 inhibitor in a patient with acquired C1-inhibitor deficiency syndrome. J Allergy Clin Immunol. 1991;88:908-918.
18. Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267-274.
19. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71:206-215.
20. Bork K, Siedlecki K, Bosch S, et al. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc. 2000;75:349- 354.
21. Van Dellen RG, Myers RP. Bladder involvement in hereditary angioedema. Mayo Clin Proc. 1980;55:277-278.
22. Sugiyama E, Ozawa T, Taki H, et al. Hereditary angioedema with a de novo mutation of exon 8 in the C1 inhibitor gene showing recurrent edema of the hands around the peripheral joints. Arthritis Rheum. 2001;44:974-977.
23. Karim Y, Griffiths H, Deacock S. Normal complement C4 values do not exclude hereditary angioedema. J Clin Pathol. 2004;57:213-214.
24. Gadek JE, Hosea SW, Gelfand JA, et al. Replacement therapy in hereditary angioedema. N Engl J Med. 1980;302:542-546.
25. Cicardi M, Zingale L. How do we treat patients with hereditary angioedema. Tranfus Apheresis Sci. 2003;29:221-227.
26. Frank MM, Sergent JS, Kane MA, et al. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med. 1972;286:808-812.
27. Ritchie B. Protease inhibitors in the treatment of hereditary angioedema. Transfus Apheresis Sci. 2003;29:259-267.
28. Mc Glinchey PG, McCluskey DR. Hereditary angioedema precipitated by estrogens replacement therapy in a menopausal women. Am J Med Sci. 2000;320:212-213.
29. Warin RP, Cunliffe WJ, Greaves MW, et al. Recurrent angioedema: Familial and estrogens induced. Br J Dermatol. 1986;115:731-4.
30. Bouillet L, Ponard D, Drouet C, et al. Angioedema and oral contraception. Dermatology. 2003;206:106-109.
31. Agostoni A, Cicardi M. Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency. Am J Med. 1991;90: 278.
32. Sabroe RA, Kobza Black A. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol. 1997;136:153-158.
33. Cicardi M, Zingale LC, Bergamaschini L, et al. Angioedema associated with angiotensin-converting enzyme inhibitor use. Arch Intern Med. 2004;164:910-913.